Diagnostic brain MRI findings in primary progressive multiple sclerosis

被引:17
作者
Kremenchutzky, M
Lee, D
Rice, GPA
Ebers, GC
机构
[1] London Hlth Sci Ctr UC, Dept Clin Neurol Sci, London, ON N6A 5A5, Canada
[2] London Hlth Sci Ctr UC, Dept Neuroradiol, London, ON N6A 5A5, Canada
关键词
primary progressive-multiple sclerosis; magnetic resonance imaging; diagnostic criteria;
D O I
10.1177/135245850000600205
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The clinical course of multiple sclerosis con be classified as relapsing from onset (relapsing-remitting). or progressive from onset (primary progressive-PPMS). These clinical phenotypes have been based on historical and clinical observations. It has been reported that PPMS patients tend to have quantitatively less MRI activity and disease burden. We evaluated the sensitivity and diagnostic value of conventional brain MRI scan in 143 PPMS patients. Brain MRIs were blindly evaluated to determine if they satisfied Paty and/or fazekas diagnostic criteria. Patients were divided into those with typical, atypical or normal scans. They satisfied brain MRI criteria in 92% cases. Findings included: 131 typical, four atypical, and eight normal scans. All 12 non-typical scans' subjects had spinal onset; spinal MRI scans were positive in four of seven cases. Sew, age of onset, site and number of symptoms involved at onset among those groups were not significantly different but accumulation of disability had a tendency to be slower in these few individuals with normal or atypical head MRI's Although there may be quantitative differences in lesion activity/burden, MRI scanning in PPMS unexpectedly has diagnostic sensitivity very similar to that seen in RRMS. A normal brain MRI is unusual in PPMS patients.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 34 条
[1]  
BAKER AB, 1968, EPIDEMIOLOGY MULTIPL, P14
[2]   The natural history of multiple sclerosis: a geographically based study - 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis [J].
Cottrell, DA ;
Kremenchutzky, M ;
Rice, GPA ;
Hader, W ;
Baskerville, J ;
Ebers, GC .
BRAIN, 1999, 122 :641-647
[3]   The natural history of multiple sclerosis: a geographically based study - 5. The clinical features and natural history of primary progressive multiple sclerosis [J].
Cottrell, DA ;
Kremenchutzky, M ;
Rice, GPA ;
Koopman, WJ ;
Hader, W ;
Baskerville, J ;
Ebers, GC .
BRAIN, 1999, 122 :625-639
[4]  
Dean A.G, 1995, EPI INFO VERSION 6 W
[5]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[6]   Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].
Ebers, GC ;
Rice, G ;
Lesaux, J ;
Paty, D ;
Oger, J ;
Li, DKB ;
Beall, S ;
Devonshire, V ;
Hashimoto, S ;
Hooge, J ;
Kastrukoff, L ;
Krieger, C ;
Mezei, M ;
Seland, P ;
Vorobeychi, G ;
Morrison, W ;
Nelson, J ;
Freedman, MS ;
Chrisie, S ;
Nelson, R ;
Rabinovitch, H ;
Freedman, C ;
Hartung, HP ;
Rieckmann, P ;
Archelos, J ;
Jung, S ;
Weilbach, F ;
Flachenecke, P ;
Sauer, J ;
Hommes, O ;
Jongen, P ;
Brouwer, S ;
McLeod, J ;
Pollard, J ;
Ng, R ;
Sandberg-Wollheim, M ;
Källén, K ;
Nilsson, P ;
Ekberg, R ;
Lundgren, A ;
Jadbäck, G ;
Wikström, J ;
Multanen, J ;
Valjakka, M ;
Carton, H ;
Lissoir, F ;
Declerq, I ;
Vieren, M ;
Peeters, E ;
Dubois, B .
LANCET, 1998, 352 (9139) :1498-1504
[7]   CRITERIA FOR AN INCREASED SPECIFICITY OF MRI INTERPRETATION IN ELDERLY SUBJECTS WITH SUSPECTED MULTIPLE-SCLEROSIS [J].
FAZEKAS, F ;
OFFENBACHER, H ;
FUCHS, S ;
SCHMIDT, R ;
NIEDERKORN, K ;
HORNER, S ;
LECHNER, H .
NEUROLOGY, 1988, 38 (12) :1822-1825
[8]   Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis [J].
Filippi, M ;
Horsfield, MA ;
Tofts, PS ;
Barkhof, F ;
Thompson, AJ ;
Miller, DH .
BRAIN, 1995, 118 :1601-1612
[9]   Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis [J].
Filippi, M ;
Horsfield, MA ;
Adèr, HJ ;
Barkhof, F ;
Bruzzi, P ;
Evans, A ;
Frank, JA ;
Grossman, RI ;
McFarland, HF ;
Molyneux, P ;
Paty, DW ;
Simon, J ;
Tofts, PS ;
Wolinsky, JS ;
Miller, DH .
ANNALS OF NEUROLOGY, 1998, 43 (04) :499-506
[10]   Magnetic resonance imaging in the differential diagnosis and monitoring of the treatment of multiple sclerosis [J].
Filippi, M ;
Miller, DH .
CURRENT OPINION IN NEUROLOGY, 1996, 9 (03) :178-186